COVID-19 response
In response to the COVID-19 outbreak, we are offering Algocyte®, our rapid blood testing AI technology, to any NHS and health organisation that needs help monitoring the health and immune system of non-COVID-19 patients, at a highly subsidised cost.
|
Oxford Immune Algorithmics (OIA) is an award-winning Bio and MedTech company incubated by the University of Oxford, now operating multinationally, which builds technology to move healthcare away from its reliance on population-wide symptom pattern matching toward value-based precision medicine and personalised diagnostics.
Based on model-driven machine learning developed by the team, OIA's flagship product, Algocyte, has the capacity to learn from each user’s immune system and build personal health profiles, enabling patients and doctors to take more timely, safer and better-informed decisions. OIA's products advance current trends in telemedicine, moving from online medical appointments to smart remote blood testing for immune health monitoring. The OIA team consists of a group of professionals with advanced degrees in science and medicine. Affiliated with OIA and the universities of Oxford, Cambridge, Imperial College, and the Karolinska Institute, the team has published more than 200 papers in top-ranked journals in the areas of Artificial Intelligence, computational medicine and systems immunology. |
CE compliant under the European Medical Devices Directive UK MHRA Registration No. 09450
Harmonised ISO 13485, ISO 14971/DCB0129 Patents pending GB1918948.9, GB2020375.8 and PCT/GB2020/05328 Pandemic-ready Algocyte® is particularly useful to vulnerable patients who may put themselves at risk of infection (e.g. COVID-19) when visiting hospitals or be forced to delay their treatment because they cannot be properly monitored before or after an intervention. A world free of preventable diseases The mission of Algocyte® is to help transform healthcare from a discipline that is heavily based upon statistical symptom pattern-matching into one centred on value-based healthcare and model-driven early diagnosis by exploiting cutting-edge research on immunology, causality in cell biology, and biological complexity that our team has pioneered at some of the world's best research and medical universities. Read the feedback from patients and doctors Why Use Algocyte? |
|
|
(c) 2020 Oxford Immune Algorithmics, all rights reserved
Request more information or a demonstration
Screenshots of Algocyte, a full, rapid, remote blood testing end-to-end solution that includes an app (also available from desktop) with
two-way meaningful communication capabilities between patient and doctor matching symptoms and adverse effects to tests, performed at home, also with Algocyte.
two-way meaningful communication capabilities between patient and doctor matching symptoms and adverse effects to tests, performed at home, also with Algocyte.
|
|